HIT Consultant January 2, 2026
What You Should Know:
– In a significant move for the “tele-prescribing” landscape, the U.S. Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) have announced a fourth temporary extension of telemedicine flexibilities.
– This extension allows practitioners to prescribe controlled medications—including Schedule II–V drugs—via audio-video encounters without a prior in-person medical evaluation through December 31, 2026.
A Transitional Safety Net
The policy is a critical “lifeline” for roughly 7 million Americans who received remote prescriptions for controlled substances in 2024 alone. This fourth extension is less about a final decision and more about managing “regulatory debt.” By pushing the deadline to the end of 2026, the administration is buying time to finalize...
Today's Sponsors
Today's Sponsor